GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: ASP 3026 | ASP3026
Compound class:
Synthetic organic
Comment: ASP-3026 is a second generation ALK inhibitor designed to target ALK rearrangements which are the oncogenic drivers of some non-small cell lung cancers (NSCLCs) and T-cell lymphomas known as ALK- expressing anaplastic large-cell lymphoma (ALK+ALCL) .
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine |
Synonyms ![]() |
| ASP 3026 | ASP3026 |
Database Links ![]() |
|
| CAS Registry No. | 1097917-15-1 |
| GtoPdb PubChem SID | 223366073 |
| PubChem CID | 25134326 |
| RCSB PDB Ligand | F6O |
| Search Google for chemical match using the InChIKey | MGGBYMDAPCCKCT-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | MGGBYMDAPCCKCT |
| UniChem Compound Search for chemical match using the InChIKey | MGGBYMDAPCCKCT-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | MGGBYMDAPCCKCT-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
ASP3026 (links to external site)
Cat. No. HY-13326 |